Keyman188

Keyman188 | Joined since 2016-11-12

Investing Experience -
Risk Profile -

Followers

0

Following

0

Blog Posts

0

Threads

5,968

Blogs

Threads

Portfolio

Follower

Following

Summary
Total comments
5,968
Past 30 days
0
Past 7 days
0
Today
0

User Comments
Stock

2020-12-13 13:25 | Report Abuse

Now you are really so hai kia...

Slapping your own face......


Kesian...kesian...

Stock

2020-12-13 13:23 | Report Abuse

Before that AlvinTSK sifu asked people to sell...

Right now AlvinTSK sifu asking people to buy...

So buy or sell...kekeke...kekeke...

Stock

2020-12-13 13:22 | Report Abuse

Keyman188 always like to repeat & repeat...waiting AlvinTSK sifu comment again what he has commented earlier...kekeke...


Keyman188 nothing to do, so just traced back AlvinTSK sifu what his commented earlier.....


End of Nov'20 so much noise to treat members here to sell...


Right now suddenly turn up so defensive...


Either stuck at the middle road or "accidently" already bet in a lot of structured warrant caused until insomnia.......


Let the majority members preview......


Kekeke...kekeke...





Nov 29, 2020 8:43 PM | Report Abuse

Windfall tax is so coming !! Dont forget Muar MP is with opposition!!
https://www.nst.com.my/news/nation/2020/11/645200/budget-2021-all-eyes...


Stock: [TOPGLOV]: TOP GLOVE CORP BHD

Nov 29, 2020 8:37 PM | Report Abuse

Reminder:-

AlvinTSK Next week event recalled :-
Anwar to proved his majority and will have the budget debate (Windfall tax in sight)
https://www.google.com.my/amp/s/www.malaymail.com/amp/news/malaysia/20...

TG Ipoh faced saman and suspension which further dampen revenue and profit
https://www.google.com.my/amp/s/www.malaymail.com/amp/news/malaysia/20...

Management fund running short and to minimise SBB and EPF lost confident & continue to dump
https://www.theedgemarkets.com/article/top-glove-spends-rm21m-14th-day...

Vaccine trial beginning next week and in January
https://m.malaysiakini.com/news/552796
29/11/2020 12:10 PM


Stock: [TOPGLOV]: TOP GLOVE CORP BHD

Nov 29, 2020 8:35 PM | Report Abuse

Again, without the support of substantial player and limited management fund for SBB, see who is big enough to save this sinking ship. All that dont jump, can go drown in their sorrow!!


Stock: [TOPGLOV]: TOP GLOVE CORP BHD

Nov 29, 2020 8:31 PM | Report Abuse

Those who are stuck high, are in denial !!
Let them have a heart attack moment this coming week when the budget is reviewed and debated especially now when the opposition have the belief that they have the majority and will do whatever to oppose what is in the current budget!!

Stock

2020-12-13 13:11 | Report Abuse

Keyman188 nothing to do, so just traced back AlvinTSK sifu what his commented earlier.....


End of Nov'20 so much noise to treat members here to sell...


Right now suddenly turn up so defensive...


Either stuck at the middle road or "accidently" already bet in a lot of structured warrant caused until insomnia.......


Let the majority members preview......


Kekeke...kekeke...





Nov 29, 2020 8:43 PM | Report Abuse

Windfall tax is so coming !! Dont forget Muar MP is with opposition!!
https://www.nst.com.my/news/nation/2020/11/645200/budget-2021-all-eyes...


Stock: [TOPGLOV]: TOP GLOVE CORP BHD

Nov 29, 2020 8:37 PM | Report Abuse

Reminder:-

AlvinTSK Next week event recalled :-
Anwar to proved his majority and will have the budget debate (Windfall tax in sight)
https://www.google.com.my/amp/s/www.malaymail.com/amp/news/malaysia/20...

TG Ipoh faced saman and suspension which further dampen revenue and profit
https://www.google.com.my/amp/s/www.malaymail.com/amp/news/malaysia/20...

Management fund running short and to minimise SBB and EPF lost confident & continue to dump
https://www.theedgemarkets.com/article/top-glove-spends-rm21m-14th-day...

Vaccine trial beginning next week and in January
https://m.malaysiakini.com/news/552796
29/11/2020 12:10 PM


Stock: [TOPGLOV]: TOP GLOVE CORP BHD

Nov 29, 2020 8:35 PM | Report Abuse

Again, without the support of substantial player and limited management fund for SBB, see who is big enough to save this sinking ship. All that dont jump, can go drown in their sorrow!!


Stock: [TOPGLOV]: TOP GLOVE CORP BHD

Nov 29, 2020 8:31 PM | Report Abuse

Those who are stuck high, are in denial !!
Let them have a heart attack moment this coming week when the budget is reviewed and debated especially now when the opposition have the belief that they have the majority and will do whatever to oppose what is in the current budget!!

Stock

2020-12-13 12:48 | Report Abuse

Next week further bleeding then don't know who is so hai kia lorrr...


Wkwkwk...kekeke...

Stock

2020-12-13 12:44 |

Post removed.Why?

Stock

2020-12-13 12:36 |

Post removed.Why?

Stock

2020-12-13 12:21 | Report Abuse

Yayaya...

Only people know how to invest TG right now is smart...

Only people don't know how to invest TG right now is dumb...

Yayaya....Keyman188 also part of naive & dumb old man...

Only young investors smarter now......kekeke

General

2020-12-13 09:47 | Report Abuse

Relentless China Inflows Spur Call for Strongest Yuan Since 1993Bloomberg News

December 13, 2020, 7:00 AM GMT+8



~ Currency could rise to 6 a dollar on strong fund influx: Citi

 
~ Foreigners boosted pace of adding Chinese notes this year


The unrelenting pace of inflows heading for China’s bonds and stocks has one yuan bull predicting the currency could strengthen to a level not seen in nearly three decades.

A “flood” of foreign cash will chase yuan-denominated assets in 2021 because they’ll offer far better yield than the rest of the world, according to Liu Li-gang, chief China economist at Citigroup Inc. He predicts the currency could rally 10% to 6 per dollar -- or even more -- by the end of next year. The yuan hasn’t been that strong since late 1993, just before China’s unification of official and market exchange rates triggered a plunge in the currency.

The yuan has been on a tear since late May, surging to a more than two-year high as data showed that China’s economy was rebounding from the virus pandemic. Overseas funds have increased their holdings of onshore bonds and stocks by more than 30% this year to records, official data showed, prompted by index inclusions and the country’s wide interest-rate premium over other markets. To slow the advance, Beijing has made it cheaper for traders to bet against the yuan and has relaxed capital curbs to allow more outflows. But those measures have done little to dampen optimism.

That puts the People’s Bank of China in a policy quandary. It needs to narrow the yuan’s yield premium over the rest of the world to slow the appreciation, as too strong a currency could undermine its push to support an economic rebound that’s reliant on global demand for Chinese exports. Meanwhile, it wants to keep interest rates elevated, as Beijing’s earlier stimulus helped fuel a rapid buildup in leverage, sending an indicator for the country’s debt levels to a record high.

“The problem China faces next year will be huge, unrelenting capital inflow,” Citi’s Liu said. “The yuan’s appreciation will be a key threat to China’s macro economy.”


The Chinese currency has strengthened nearly 10% from this year’s low in late May, making it the second best performer in Asia following the South Korean won. The yuan traded at 6.5460 on Friday.

The yield on China’s 10-year government bonds climbed in recent months on speculation the PBOC will start to exit monetary stimulus. That has helped widen the yuan’s interest-rate advantage over the dollar to the largest on record. Also, the currency is supported by bets that Washington may be less hostile toward Beijing under a Joe Biden administration. A global index compiler’s decision to add some onshore notes in its flagship indexes and a weaker dollar also contributed to the appreciation.

CONT......


##https://www.bloomberg.com/news/articles/2020-12-12/relentless-china-inflows-spur-call-for-strongest-yuan-since-1993?srnd=premium-asia

Stock

2020-12-13 02:25 |

Post removed.Why?

Stock

2020-12-12 22:19 |

Post removed.Why?

Stock

2020-12-12 21:34 | Report Abuse

Keyman188 still can recall...


Past few months back during MCO...CMCO...or...lock down everywhere...


TG players very happy & laughing others who are suffering because all other sectors so much selling pressure until no eye see...


But now come back to TG become factory CMCO + penalty once if found guilty on SOP not meet...


Right now more worsen, top investment bank in the world (JP Morgan) had revised lower target price to reflect upcoming earnings prospects...


So end up TG this few weeks become targeted selling pressure...


Is it called karma + retribution!!!...


人在做...天在看...

Stock

2020-12-12 21:28 | Report Abuse

Keyman188 always like to repeat & repeat to remind ourselves...


Since top investment bank, JP Morgan had given glove sector outlook......


Time to wake up lorrr......


Big Boy already earned full full liao...


Now only late comer turn in keep on struggling...


SO KESIAN late comer players everyday insomnia nowadays...


Everyday carrying bomb to your life unless you plan to invest for next 10 years or 20 years...


If still putting hope towards 10.00 level...hmmm...


" Don't hope, hope become your killer"...

Stock

2020-12-12 21:24 | Report Abuse

Don't mentioned coward name lahhh......

Keyman188 not so favour mentioned member's name...not so nice mahhh......

We all are humble members mahhh......



Posted by stkoay > Dec 12, 2020 9:15 PM | Report Abuse

shareinvestor88 has taken her medicine I suppose.....

Stock

2020-12-12 21:11 | Report Abuse

Keyman188 always like to repeat & repeat everday to sohai + dumb coward...


OMG...still strong holding above 4.60 liao...


Where is karma + retribution sohai + dumb coward hiding !!!


We all so long didn't heard "are you creating panic"...."please don't spread panic"...."No hope , sell"...."BUY BUY or BYE BYE"....


Hello are you still alive !!!....Don't be coward hiding now......


Genting Group shareholders need you now to give more & more speech...


A lot of members here still not enough accumulation QUOTA......


Where is your tp 2 / 2.50 !!!......



Long long waiting until the neck longer than giraffe......kekeke...kekeke...

News & Blogs

2020-12-12 21:08 | Report Abuse

Aiyo...no need talk about Supermax also affected going down lahh....

Multiple effect mahh....

If all glove makers share price going down, you think Supermax can be exceptional !!!......

News & Blogs

2020-12-12 21:02 | Report Abuse

Honestly speaking, Keyman188 will only start accumulating after the pricing is rationalised after 2022...

Perhaps below RM 3.00 is much more safety margin for the longer term position...


Cheerssss.............

News & Blogs

2020-12-12 21:01 | Report Abuse

Accept the fact & reality...

Right now only left small potato defending...defending...everyday...

Big Boy already harvest their handsome profit...

Keyman188 doesn't say TG no fundament but the market is the time to rationlise & normalise the real pricing after 2021...

Keyman188 look at the JP Morgan preview, is the reality fact for the target price...

General

2020-12-12 20:56 | Report Abuse

FDA approves Pfizer’s Covid vaccine for emergency use as U.S. reaches pivotal moment in the pandemic.

(Published Fri, Dec 11 20209:31 PM ESTUpdated Fri, Dec 11 202010:48 PM EST)


~ FDA Chief Scientist Denise Hinton told Pfizer in a letter Friday that she was authorizing the emergency use of the company’s vaccine.

~ The FDA’s emergency use authorization will now kick-start the federal government’s distribution of the potentially lifesaving doses to 64 states, territories and major cities across the nation.

~ The government plans to distribute 2.9 million doses of the vaccine within 24 hours, followed by an additional 2.9 million doses 21 days later for patients to get their second shot.


The Food and Drug Administration has approved Pfizer and BioNTech’s coronavirus vaccine for emergency use, a monumental turning point in the once-in-a-century pandemic that has taken nearly 300,000 American lives in less than a year and wreaked havoc on the U.S. economy.

FDA Chief Scientist Denise Hinton told Pfizer in a letter Friday that she was authorizing the emergency use of the company’s vaccine.

President Donald Trump called it a “medical miracle” in a video tweet. “We’ve delivered a safe and effective vaccine in just 9 months,” Trump said. “This is one of the greatest scientific accomplishments in history.”

Dr. Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research, said the decision “holds the promise to alter the course of this pandemic in the United States.”“With science guiding our decision-making, the available safety and effectiveness data support the authorization of the Pfizer-BioNTech COVID-19 Vaccine because the vaccine’s known and potential benefits clearly outweigh its known and potential risks,” he said.

The FDA’s emergency use authorization will now kick-start the federal government’s distribution of the potentially lifesaving doses to 64 states, territories and major cities across the nation. The government plans to distribute 2.9 million doses of the vaccine within 24 hours, followed by an additional 2.9 million doses 21 days later for patients to get their second shot, Gen. Gustave Perna, who oversees logistics for President Donald Trump’s vaccine program Operation Warp Speed, said Wednesday. Pfizer’s vaccine requires two doses administered three weeks apart.

The vaccine could not come at a more crucial time. Hospitals across the U.S. already have a higher load of Covid patients than ever before, and the country’s outbreak is primed to set even more grim records. The U.S. reported 3,124 new Covid-19 deaths on Wednesday, the deadliest single-day tally of the pandemic so far, according to a CNBC analysis of Johns Hopkins University data. The director of the Centers for Disease Control and Prevention, Dr. Robert Redfield, warned earlier this month that the next few months of the pandemic would be among “the most difficult in the public health history of this nation.”

Initial doses of Pfizer’s vaccine will be limited as manufacturing ramps up, with officials predicting it will take months to immunize everyone in the U.S. who wants to be vaccinated. Pfizer has said it plans to ship 50 million vaccine doses this year, enough to inoculate 25 million people. The vaccine is expected to be distributed in phases with the most critical U.S. workers and vulnerable people getting it first. The CDC has provided states with an outline that recommends prioritizing health-care workers and nursing homes first, but states can distribute the vaccine as they see fit.

An emergency use authorization, or EUA, isn’t the same as a full approval, which can typically take months. Pfizer has only submitted two months of follow-up safety data, but the agency usually requires six months for full approval. The vaccine was authorized for people 16 and older.

On Friday, FDA Commissioner Stephen Hahn said the agency was “rapidly” working toward clearing the vaccine for emergency use. Shortly after Hahn’s statement, Trump, who has repeatedly said that he pushed the FDA to move more quickly in the vaccine development process, told the agency in a tweet to “Get the dam vaccines out NOW.”

The FDA’s announcement comes after a key agency advisory panel on Thursday voted 17 to 4 with one abstention to recommend the vaccine for emergency authorization. The Vaccines and Related Biological Products Advisory Committee plays a key role in approving flu and other vaccines in the U.S., verifying the shots are safe for public use. While the FDA doesn’t have to follow the advisory committee’s recommendation, it often does.

Cont...


##https://www.cnbc.com/2020/12/11/pfizer-covid-vaccine-approved-fda-emergency-use.html

General

2020-12-12 20:52 | Report Abuse

Just retreat recent outlook by analyst...


Stronger corporate earnings expected in 2021

(RHB Wealth Research / theedgemarkets.com / October 19, 2020 00:00 am +08)

An unwelcome visitor in early 2020 — Covid-19 — took investors by surprise. The deadliness of the virus was not known until the World Health Organization declared the outbreak as a pandemic in early March. By then, the virus had spread all over the world and the number of new cases had spiked, prompting governments throughout the world to implement unprecedented measures. Borders and economies were closed to prevent the virus from spreading faster while scientists worldwide raced to find a vaccine.

The Malaysian government prioritised people’s health over the economy as global and domestic Covid-19 infections and deaths increased. It introduced the Movement Control Order (MCO) from March 18, followed by the Conditional MCO and then Recovery MCO.

The strict lockdown and border closures have adversely affected the economy. GDP in the second quarter of 2020 shrank sharply and was worse than during both the Asian and global financial crises (AFC and GFC). Malaysia recorded the worst quarterly GDP numbers in 2Q2020, plunging 17.1% year on year. It was also the most badly affected economy in Southeast Asia.

The government unveiled RM250 billion in economic stimulus, or 17% of GDP, in the first quarter of 2020. As the number of new Covid-19 cases increased sharply in recent weeks, the government announced an extension of the previous economic stimulus packages on Sept 23, bringing the total value of economic stimulus to an estimated RM295 billion, or 20% of GDP, with direct fiscal injection estimated at RM45 billion, or 3% of GDP, to counter the uncertainty surrounding domestic and global economic recovery.

Bank Negara Malaysia has also been cutting interest rates since the beginning of the year, from 3% to 1.75% to boost the economy.

The aggressive interest rate cut has resulted in a drop in 10-year government bond yields to a historical low of 2.39%, which is even lower than during the GFC’s 2.97%. In addition, Bank Negara had introduced a six-month automatic loan moratorium from April 1 to Sept 30. The waiver of debt service obligations is estimated at RM100 billion over the six-month automatic loan moratorium.

This has resulted in a liquidity surge in the local stock market as retail players search for better-yielding assets. Local retail participation has increased significantly in 2020. Apart from the liquidity, Bursa Malaysia’s ban of short selling on stocks also contributed to the positive market sentiment and the ban will continue until year-end.

Bursa Malaysia’s turnover velocity and average value and volume traded increased significantly in the first half of 2020 (1H2020). This was due to higher participation from retail investors seeking higher returns, as fixed deposits returns have dropped substantially and investors also have more money in their pockets.

Retail participation has increased from an average of 24% from 2010 to 2019, to 33% in 1H2020, while institutional participation decreased to 67%, from an average of 76% over the past 10 years. Whilst, foreign participation has decreased further to 21% in 1H2020 compared with the average of 29% over the past 10 years.

Foreign portfolio managers have been selling Malaysian equity, owing to a less attractive earnings outlook for Malaysian corporates. Year-to-date (YTD) foreign outflows in equity are RM21.7 billion.

Foreign shareholding of Malaysia equities also fell substantially from above 24% in February 2018 to 20.8% in August 2020. This level is near the 20.7% level touched during the GFC.

The index has been trending down since touching its high of 1,611.42 on July 29. As at Sept 30, the index is down 6.6% on concerns over a selloff by retail investors, owing to the end of the six-month automatic loan moratorium on Sept 30; the escalation of tensions between the US and China as the Trump administration continues to add to the number of blacklisted sectors and companies; and fear of the delay in the recovery of the economy globally, owing to a recent spike in the number of Covid-19 cases globally.


Cont...

##https://www.theedgemarkets.com/content/advertise/stronger-corporate-earnings-expected-2021

General

2020-12-12 20:48 | Report Abuse

Right now KLCI at the bullish trend ahead with the market sentiment recovery in term of global earnings & global economy


~ More & more vaccine will be rolling out to the worldwide emergency treaatment (such as Pfizer, Moderna, AstraZeneca, Oxford, etc...)


~ MALAYSIA's gross domestic product (GDP) is expected to grow between 6.5% and 7.5% in 2021


~ Smaller contraction, with significant improvement in economic activity in Malaysia at Q3 2020


~ Most majority segments (such as, wholesale & retail trade; industrial production; gross exports; domestic credit spending; manufacturing PMI, etc...) at the momentum of recovery for the upcoming few quarters


~ share market pricing driven by Stronger corporate earnings expected in 2021

Stock

2020-12-12 14:06 | Report Abuse

Time to wake up for switching to recovery stocks......


KLCI index started from 1607 towards 1689 within 2 weeks....


BuT


Dpharma share price started to rationalise from 4.05 towards 3.71 within 2 weeks....(the current level still not yet bottom)


Let the real fact inform the market.....



Cheers......

Stock

2020-12-12 14:00 | Report Abuse

Let us check the real fact...


One week before closing price of this stock @ 3.90...


After one week closing price of this stock @ 3.71...(After latest vaccine development & so many effective vaccine rollout)


Comparison the fact...


One week before closing KLCI index @ 1621.85...


After one week closing KLCI index @ 1684...(Higher index level @ 1689)...(After latest vaccine development & so many effective vaccine rollout)


So what the real fact or signal given to investors or traders !!!....








Posted by Keyman188 > Dec 5, 2020 2:46 PM | Report Abuse X

Let us check the real fact...


One week before closing price of this stock @ 4.05...


After one week closing price of this stock @ 3.90...(After latest vaccine development & rollout)


Comparison the fact...


One week before closing price of KLCI index @ 1607.59...


After one week closing price of KLCI index @ 1621.85...(Higher index level @ 1628.82)...(After latest vaccine development & rollout)


So what the real fact or signal given to investors or traders !!!....

Stock

2020-12-11 09:14 | Report Abuse

Muhibbah business also involving energy sector....

1) EPCIC OF WELLHEAD PLATFORM FOR OPHIR DEVELOPMENT PROJECT

2) TERENGGANU GAS TERMINAL PROJECT (TGAST)

3) RGT1 MINIMUM SEND OUT CAPABILITY IMPROVEMENT PROJECT

4) PETRONAS LNG TRAIN 9, STEEL STRUCTURE ERECTION WORK, BINTULU, SARAWAK

5) EPCIC ALLIANCE FOR THE LNG REGASIFICATION UNIT, ISLAND BERTH AND SUBSEA PIPELINE LEKAS PROJECT, MALACCA

6) EPCC OF THE CENTRAL OIL DISTRIBUTION (CODT) TERMINAL AT TG MANIS MUKAH, SARAWAK

7) YEMEN LNG PROJECT

8) HORIZON BULK LIQUID PRODUCTS TERMINAL ON JURONG ISLAND, SINGAPORE

9) LIQUID BULK TERMINAL PROJECT, WEST PORT, MALAYSIA

10) MG3 LUBE PLANT PROJECT, MALAYSIA

11) LNG3 BERTH BINTULU PORT, BINTULU, SARAWAK

Stock

2020-12-10 15:19 | Report Abuse

Well prepare for upcoming momentum......


Cheers.............

Stock

2020-12-10 00:18 | Report Abuse

Keyman188 really naive.......

Sovereign debt increased, any related to glove sector???....

So need any sifu or masters give some guidance lorrr......



Posted by ChaseBros > Dec 10, 2020 12:15 AM | Report Abuse 

https://www.cnbc.com/2020/12/09/european-central-bank-set-to-increase-...

If it is clear and shiny, affluent countries wouldn't be expanding and extending the stimulus well into end of 2021. More bankruptcies and deaths are imminent. If you have friends working in the financial dept of the banks, you'll get to hear the horrendous NPL rolling-in especially selective banks which are bound to do "national-service" will see a huge write-off.

Stock

2020-12-10 00:02 | Report Abuse

Keyman188 always is humble person...


But sometimes so many iddiots given wrong facts or fake info....


Then give chance to Keyman188 to bully or curse until whole families become victims.......


Keyman188 always can accept reality or negative news but hard to accept fake......

Stock

2020-12-10 00:01 | Report Abuse

Keyman188 always is humble person...


But sometimes so many iddiots given wrong facts or fake info....


Then give chance to Keyman188 to bully or curse until whole families become victims.......


Keyman188 always can accept reality or negative news but hard to accept fake......

Stock

2020-12-09 23:55 | Report Abuse

Keyman188 always like to repeat & repeat everday to sohai + dumb coward...


OMG...still strong holding above 2.50 liao...


Where is karma + retribution sohai + dumb coward hiding !!!


We all so long didn't heard "are you creating panic"...."please don't spread panic"...."No hope , sell"...."BUY BUY or BYE BYE"....


Hello are you still alive !!!....Don't be coward hiding now......


Genting Group shareholders need you now to give more & more speech...


A lot of members here still not enough accumulation QUOTA......


Where is your tp 1 / 1.50 !!!......



Long long waiting until the neck longer than giraffe......kekeke...kekeke...

Stock

2020-12-09 23:54 | Report Abuse

Keyman188 always like to repeat & repeat everday to sohai + dumb coward...


OMG...still strong holding above 4.30 liao...


Where is karma + retribution sohai + dumb coward hiding !!!


We all so long didn't heard "are you creating panic"...."please don't spread panic"...."No hope , sell"...."BUY BUY or BYE BYE"....


Hello are you still alive !!!....Don't be coward hiding now......


Genting Group shareholders need you now to give more & more speech...


A lot of members here still not enough accumulation QUOTA......


Where is your tp 2 / 2.50 !!!......



Long long waiting until the neck longer than giraffe......kekeke...kekeke...

Stock

2020-12-09 23:51 |

Post removed.Why?

Stock

2020-12-09 23:50 |

Post removed.Why?

Stock

2020-12-09 17:16 | Report Abuse

Based on the latest balance sheet...

TG nett cash position only left RM 776 million even though huge profit by latest quarter...

Most of the fund used it at investment securities (share buy back) by about RM 2,678 million......

If keep on share buy back, for sure cash position will be lesser & lesser...

So far we can see at Bursa Malaysia nowadays, only TG so crazy share buy back aggressively by this few months by spending billion billion dollar....

Stock

2020-12-09 16:41 | Report Abuse

Is it the Big...Big...joke or kidding !!!......

After quarterly report with so strong result also heavily selling pressure !!!......

For sure 1 thing...SMART money already gone & start swifting to recovery counters......

Stock

2020-12-09 11:49 | Report Abuse

This counter not suitable for those fast money players...


This counter is for storage purpose...is for "Orang Tua" keep it for the next 10 years or 20 years or 30 years...


Don't expect fast jump up like other fancy counters...


You see Keyman188' HLFG today...already break 18.00 liao...cheers...

Stock

2020-12-09 11:22 | Report Abuse

OMG....Keyman188 forget to check this GOLDEN turtle moving......

So ONG today...already break 18.00 liao.......

No wonder Keyman188 always putting at "Diamond Box"...

Stock

2020-12-09 10:35 | Report Abuse

Further downside risk by this week to 3.50 ~ 3.55......

Stock

2020-12-08 23:59 | Report Abuse

Keyman188 always like to repeat & repeat to sohai + dumb coward...


OMG...still strong holding above 2.50 liao...


Where is karma + retribution sohai + dumb coward hiding !!!


We all so long didn't heard "are you creating panic"...."please don't spread panic"...."No hope , sell"...."BUY BUY or BYE BYE"....


Hello are you still alive !!!....Don't be coward hiding now......


Genting Group shareholders need you now to give more & more speech...


A lot of members here still not enough accumulation QUOTA......


Where is your tp 1 / 1.50 !!!......



Long long waiting until the neck longer than giraffe......kekeke...kekeke...

Stock

2020-12-08 23:56 | Report Abuse

Keyman188 always like to repeat & repeat to sohai + dumb coward...


OMG...still strong holding above 4.40 liao...


Where is karma + retribution sohai + dumb coward hiding !!!


We all so long didn't heard "are you creating panic"...."please don't spread panic"...."No hope , sell"...."BUY BUY or BYE BYE"....


Hello are you still alive !!!....Don't be coward hiding now......


Genting Group shareholders need you now to give more & more speech...


A lot of members here still not enough accumulation QUOTA......


Where is your tp 2 / 2.50 !!!......



Long long waiting until the neck longer than giraffe......kekeke...kekeke...

Stock

2020-12-08 23:23 | Report Abuse

FDA says Pfizer Covid vaccine provides some protection after first dose, meets success criteria

PUBLISHED TUE, DEC 8 20208:04 AM ESTUPDATED TUE, DEC 8 202010:08 AM EST


~ The FDA said data from Pfizer’s coronavirus vaccine trials was “consistent” with recommendations put forth by the agency for an emergency use authorization.

~ FDA staff also said data submitted appeared to show the vaccine provided protection after the first dose.

~ It added that two doses of the vaccine were “highly effective” in preventing confirmed cases of Covid-19.



The Food and Drug Administration said Tuesday that data from Pfizer’s coronavirus vaccine trials was consistent with recommendations put forth by the agency for an emergency use authorization. It also said the vaccine was highly effective and did not raise any specific safety concerns.

In documents published ahead of an advisory meeting Thursday to review Pfizer’s vaccine, FDA staff also said data submitted appeared to show the vaccine was 82% effective after the first dose. Pfizer’s vaccine recommends two doses about three weeks apart. The agency added that two doses of the vaccine were “highly effective” in preventing confirmed cases of Covid-19 at least seven days following the second dose.

The FDA has indicated it would authorize a vaccine that’s safe and at least 50% effective. The flu vaccine, by comparison, generally reduces people’s risk of getting influenza by 40% to 60% compared with people who aren’t inoculated, according to the CDC.

“As such, FDA has determined that the Sponsor has provided adequate information to ensure the vaccine’s quality and consistency for authorization of the product under an EUA,” the agency said on its website.

The FDA is expected to decide on whether to authorize Pfizer’s vaccine within days. The U.K. on Tuesday began mass inoculations with the vaccine based on its approval of emergency use.

The documents posted Tuesday offer a glimpse of the FDA’s view of the vaccine. The agency is scheduled to convene a meeting of its Vaccines and Related Biological Products Advisory Committee, a group of outside medical experts, on Thursday to review Pfizer’s Covid-19 vaccine with German drugmaker BioNTech for emergency use.

Emergency use authorization means the FDA will allow some people to receive the vaccine as the agency continues to evaluate data. It isn’t the same as a full approval, which can typically take months. The FDA granted emergency clearance for Gilead Sciences’ remdesivir in May before giving full approval in late October.


Cont...

Stock

2020-12-08 23:21 | Report Abuse

FDA says Pfizer Covid vaccine provides some protection after first dose, meets success criteria

PUBLISHED TUE, DEC 8 20208:04 AM ESTUPDATED TUE, DEC 8 202010:08 AM EST


~ The FDA said data from Pfizer’s coronavirus vaccine trials was “consistent” with recommendations put forth by the agency for an emergency use authorization.

~ FDA staff also said data submitted appeared to show the vaccine provided protection after the first dose.

~ It added that two doses of the vaccine were “highly effective” in preventing confirmed cases of Covid-19.



The Food and Drug Administration said Tuesday that data from Pfizer’s coronavirus vaccine trials was consistent with recommendations put forth by the agency for an emergency use authorization. It also said the vaccine was highly effective and did not raise any specific safety concerns.

In documents published ahead of an advisory meeting Thursday to review Pfizer’s vaccine, FDA staff also said data submitted appeared to show the vaccine was 82% effective after the first dose. Pfizer’s vaccine recommends two doses about three weeks apart. The agency added that two doses of the vaccine were “highly effective” in preventing confirmed cases of Covid-19 at least seven days following the second dose.

The FDA has indicated it would authorize a vaccine that’s safe and at least 50% effective. The flu vaccine, by comparison, generally reduces people’s risk of getting influenza by 40% to 60% compared with people who aren’t inoculated, according to the CDC.

“As such, FDA has determined that the Sponsor has provided adequate information to ensure the vaccine’s quality and consistency for authorization of the product under an EUA,” the agency said on its website.

The FDA is expected to decide on whether to authorize Pfizer’s vaccine within days. The U.K. on Tuesday began mass inoculations with the vaccine based on its approval of emergency use.

The documents posted Tuesday offer a glimpse of the FDA’s view of the vaccine. The agency is scheduled to convene a meeting of its Vaccines and Related Biological Products Advisory Committee, a group of outside medical experts, on Thursday to review Pfizer’s Covid-19 vaccine with German drugmaker BioNTech for emergency use.

Emergency use authorization means the FDA will allow some people to receive the vaccine as the agency continues to evaluate data. It isn’t the same as a full approval, which can typically take months. The FDA granted emergency clearance for Gilead Sciences’ remdesivir in May before giving full approval in late October.


Cont...


##https://www.cnbc.com/2020/12/08/fda-says-pfizer-covid-vaccine-data-did-not-raise-safety-concerns.html

Stock

2020-12-08 23:19 | Report Abuse

FDA says Pfizer Covid vaccine provides some protection after first dose, meets success criteria

PUBLISHED TUE, DEC 8 20208:04 AM ESTUPDATED TUE, DEC 8 202010:08 AM EST


~ The FDA said data from Pfizer’s coronavirus vaccine trials was “consistent” with recommendations put forth by the agency for an emergency use authorization.

~ FDA staff also said data submitted appeared to show the vaccine provided protection after the first dose.

~ It added that two doses of the vaccine were “highly effective” in preventing confirmed cases of Covid-19.



The Food and Drug Administration said Tuesday that data from Pfizer’s coronavirus vaccine trials was consistent with recommendations put forth by the agency for an emergency use authorization. It also said the vaccine was highly effective and did not raise any specific safety concerns.

In documents published ahead of an advisory meeting Thursday to review Pfizer’s vaccine, FDA staff also said data submitted appeared to show the vaccine was 82% effective after the first dose. Pfizer’s vaccine recommends two doses about three weeks apart. The agency added that two doses of the vaccine were “highly effective” in preventing confirmed cases of Covid-19 at least seven days following the second dose.

The FDA has indicated it would authorize a vaccine that’s safe and at least 50% effective. The flu vaccine, by comparison, generally reduces people’s risk of getting influenza by 40% to 60% compared with people who aren’t inoculated, according to the CDC.

“As such, FDA has determined that the Sponsor has provided adequate information to ensure the vaccine’s quality and consistency for authorization of the product under an EUA,” the agency said on its website.

The FDA is expected to decide on whether to authorize Pfizer’s vaccine within days. The U.K. on Tuesday began mass inoculations with the vaccine based on its approval of emergency use.

The documents posted Tuesday offer a glimpse of the FDA’s view of the vaccine. The agency is scheduled to convene a meeting of its Vaccines and Related Biological Products Advisory Committee, a group of outside medical experts, on Thursday to review Pfizer’s Covid-19 vaccine with German drugmaker BioNTech for emergency use.

Emergency use authorization means the FDA will allow some people to receive the vaccine as the agency continues to evaluate data. It isn’t the same as a full approval, which can typically take months. The FDA granted emergency clearance for Gilead Sciences’ remdesivir in May before giving full approval in late October.


Cont...


##https://www.cnbc.com/2020/12/08/fda-says-pfizer-covid-vaccine-data-did-not-raise-safety-concerns.html

Stock

2020-12-08 18:03 | Report Abuse

Offer price unable justified by upcoming fruitful results...

Definitely NOT fair......

Better reject the offer......